Australia (AU)
United States
Alleviant Medical Inc. has secured U.S. Patent No. 12290305 for its ‘Transcatheter device for interatrial anastomosis’, a breakthrough in treating heart failure without permanent implants. The new device offers a minimally invasive solution for pressure relief in the heart’s upper chambers, potentially transforming care for millions of patients.
Implant-Free Innovation for Heart Failure
This device uses radiofrequency energy to create a precise hole in the heart’s septum, establishing a controlled left-to-right atrial shunt. Unlike other methods, it avoids leaving any implant behind, which may lower complication risks and improve long-term outcomes. The goal is to reduce elevated left atrial pressure, a key issue in heart failure with preserved or reduced ejection fraction.
Regulatory Momentum and Trial Readiness
The technology has earned Breakthrough Device designation from the FDA. Alleviant is preparing for pivotal trials, including the ALLAY-HFrEF study, to evaluate safety and efficacy in symptomatic patients who have not responded to conventional treatments.
Potential for Widespread Impact
Heart failure remains a leading cause of hospitalization. This solution offers new hope for patients seeking effective therapy without added surgical burden. If clinical success follows, this could mark a significant shift in interventional cardiology.
Learn More:
Are you developing new or improved products, or thinking of applying for a patent? Did you know your research work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? To find out more, please check out our free online eligibility test.
Feel free to book a quick teleconference with one of R&D Tax specialists if you would like to learn more about R&D Tax Credit opportunities.
Who We Are:
Swanson Reed is one of the largest Specialist R&D Tax Credit advisory firm in the United States. With offices nationwide, we are one of the only firms globally to exclusively provide R&D Tax Credit consulting services to our clients.
Swanson Reed’s Texas office provides R&D tax credit consulting and advisory services to Houston, San Antonio, Dallas, Austin, Fort Worth, El Paso, Arlington, Corpus Christi, Plano, Laredo, Lubbock, Garland, Irving, Amarillo, Grand Prairie, Brownsville, McKinney, Frisco, Pasadena, and Mesquite.
Swanson Reed hosts daily free webinars and provides free IRS CE and CPE credits for CPAs. For more information please click here or contact your usual Swanson Reed representative.
Texas Overhauls R&D Franchise Tax Credit and Advances Small‑Business Reforms
Houston-based Axiom Space has partnered with Prada to bring fashion and function to new heights – astronomical heights. The startup has unveiled their brand new spacesuit at the International Astronautical Congress in Milan.
Wales Patent of the Month – April 2025
A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.
Privacy and Complaint Policy
Copyright Notice ©
